Tom Bartel

Tom Bartel joined CDx Diagnostics in June 2015 with more than two decades of results-driven commercial diagnostics expertise and a demonstrated track record of building winning sales organizations, commercializing novel assays, and accelerating product adoption in key markets.

Tom served most recently as Sr. Sales Director, Eastern US, at Agendia, where he oversaw the profitable growth of genomic sequencing of breast cancer tumors. Prior to Agendia, Tom was the Chief Sales Officer for Genomind, a genetic testing start-up in the neuropsychiatric market. He has also served as North American Vice President of Sales for Ipsogen, a worldwide leader in blood cancer diagnostics, and Vice President at American Clinical Services (ACS), a start-up diagnostic testing company that he helped found.

During his ACS tenure, he delivered multiple successive years of annual sales growth, exceeding sales quotas and supporting the successful acquisition of ACS by Sonic Healthcare USA. Tom spent the first 11 years of his diagnostics career at Quest Diagnostics, where he served in various sales and marketing leadership roles including National Sales Director, Genomic Testing.

Tom holds a Bachelor of Science degree in industrial engineering from Rutgers University, College of Engineering.